Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: -
  • Asset Class: Equity
  • Geographic Focus: Global

Merrill Lynch Investment Solutions - Marshall Wace Tops UCITS Fund

+ Add to Watchlist

MLISMBB:LX

110.70 EUR 0.06 0.05%

As of 00:59:30 ET on 05/22/2015.

Snapshot for Merrill Lynch Investment Solutions - Marshall Wace Tops UCITS Fund (MLISMBB)

Year To Date: +1.33% 3-Month: +1.05% 3-Year: - 52-Week Range: 101.26 - 111.99
1-Month: -0.90% 1-Year: +9.09% 5-Year: - Beta vs OISEONIA: -6.14

Mutual Fund Chart for MLISMBB

No chart data available.
  • MLISMBB:LX 110.70
  • 1M
  • 1Y
Interactive MLISMBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for MLISMBB

Merrill Lynch Investment Solutions - Marshall Wace TOPS UCITS Fund is a UCITS compliant fund incorporated in Luxembourg. The Fund's objective is to provide absolute returns. The Fund will seek to preserve capital through the use of various risk management techniques, given its long term investment strategy. The Fund's G Shares are exchange traded on the Luxembourg Stock Exchange.

Inception Date: 08-29-2013 Telephone: 44-20-7996-4771
Managers: ANTHONY CLAKE
Web Site: www.merrillinvestfunds.ml.com

Fundamentals for MLISMBB

NAV (on 2015-05-22) 110.70
Assets (M) (on 2015-05-21) 2,200.94
Fund Leveraged N
Minimum Investment 1,000,000.00
Minimum Subsequent Investment 100.00

Dividends for MLISMBB

No dividends reported

Fees & Expenses for MLISMBB

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for MLISMBB

Filing Date: 09/30/2014
Name Position Value % of Total
VCA Inc 343,251 10,686,770 0.702%
Envision Healthcare Holdings I 327,962 9,003,541 0.592%
Intesa Sanpaolo SpA 3,741,101 9,001,089 0.591%
NIKE Inc 123,573 8,725,678 0.573%
NVIDIA Corp 595,034 8,690,582 0.571%
Celgene Corp 115,632 8,675,719 0.570%
Gilead Sciences Inc 102,742 8,657,737 0.569%
Merck & Co Inc 184,263 8,646,833 0.568%
Abbott Laboratories 261,445 8,607,559 0.566%
Pfizer Inc 367,535 8,603,214 0.565%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil